240 related articles for article (PubMed ID: 9915902)
1. Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine.
Wang E; Riley RT; Meredith FI; Merrill AH
J Nutr; 1999 Jan; 129(1):214-20. PubMed ID: 9915902
[TBL] [Abstract][Full Text] [Related]
2. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
3. Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1.
Qiu M; Liu X
Food Addit Contam; 2001 Mar; 18(3):263-9. PubMed ID: 11304035
[TBL] [Abstract][Full Text] [Related]
4. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
5. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks.
Tardieu D; Tran ST; Auvergne A; Babilé R; Benard G; Bailly JD; Guerre P
Chem Biol Interact; 2006 Mar; 160(1):51-60. PubMed ID: 16412405
[TBL] [Abstract][Full Text] [Related]
6. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
[TBL] [Abstract][Full Text] [Related]
7. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
[TBL] [Abstract][Full Text] [Related]
8. Elevation of sphingoid base 1-phosphate as a potential contributor to hepatotoxicity in fumonisin B1-exposed mice.
Kim DH; Lee YS; Lee YM; Oh S; Yun YP; Yoo HS
Arch Pharm Res; 2007 Aug; 30(8):962-9. PubMed ID: 17879749
[TBL] [Abstract][Full Text] [Related]
9. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
[TBL] [Abstract][Full Text] [Related]
10. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
[TBL] [Abstract][Full Text] [Related]
11. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo studies to assess the effectiveness of cholestyramine as a binding agent for fumonisins.
Solfrizzo M; Visconti A; Avantaggiato G; Torres A; Chulze S
Mycopathologia; 2001; 151(3):147-53. PubMed ID: 11678589
[TBL] [Abstract][Full Text] [Related]
13. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: growth and clinical parameters.
Rotter BA; Thompson BK; Prelusky DB; Trenholm HL; Stewart B; Miller JD; Savard ME
Nat Toxins; 1996; 4(1):42-50. PubMed ID: 8680753
[TBL] [Abstract][Full Text] [Related]
14. The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys.
van der Westhuizen L; Shephard GS; van Schalkwyk DJ
Toxicon; 2001 Jul; 39(7):969-72. PubMed ID: 11223085
[TBL] [Abstract][Full Text] [Related]
15. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
Bhandari N; He Q; Sharma RP
Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
[TBL] [Abstract][Full Text] [Related]
16. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases.
Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH
Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533
[TBL] [Abstract][Full Text] [Related]
18. The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1.
Garren L; Galendo D; Wild CP; Castegnaro M
Food Addit Contam; 2001 Sep; 18(9):850-6. PubMed ID: 11552753
[TBL] [Abstract][Full Text] [Related]
19. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor.
Humpf HU; Schmelz EM; Meredith FI; Vesper H; Vales TR; Wang E; Menaldino DS; Liotta DC; Merrill AH
J Biol Chem; 1998 Jul; 273(30):19060-4. PubMed ID: 9668088
[TBL] [Abstract][Full Text] [Related]
20. Effect of fumonisin B1 on the levels and fatty acid composition of selected lipids in rat liver in vivo.
Gelderblom WC; Smuts CM; Abel S; Snyman SD; Van der Westhuizen L; Huber WW; Swanevelder S
Food Chem Toxicol; 1997 Jul; 35(7):647-56. PubMed ID: 9301647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
